Anticardiolipin, glutamic acid decarboxylase, and antinuclear antibodies in epileptic patients

Clinical and Experimental Medicine

Volumn 3, Issue 1, 2003, Pages 32-36

  Verrotti, A ^a   Greco, R ^a   Altobelli, E ^b   Latini, G ^d   Morgese, G ^c   Chiarelli, F ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d University of Siena ^*

Author keywords

Anticardiolipin antibodies; Antinuclear antibodies; Epilepsy; Glutamic acid decarboxylase antibodies

Indexed keywords

ANTICONVULSIVE AGENT; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY;

ANTIBODY TITER; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG RESPONSE; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE;

EID: 0038696431     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102380300013     Document Type: Article

References (36)

1. Aarli JA (1993) Immunological aspects of epilepsy. Brain Dev 15:41-50
2. Duse M, Notarangelo LD, Tiberti S, Menegati E, Plebani A, Ugazio AG (1996) Intravenous immune globulin in the treatment of intractable childhood epilpsy. Clin Exp Immunol 104[Suppl 1]:71-76
3. Verrotti A, Domizio S, Chiarelli F, Sabatino G, Morgese G (1996) Immunological evaluation of children treated with antiepileptic drugs. Int J Immunopathol Pharmacol 9:23-26
4. Bouma PAD (1992) Determining the prognosis of childhood epilepsies by establishing immune abnormalities. Clin Neurol Neurosurg 94[Suppl]:54-56
5. De Ponti F, Lecchini S, Cosentino M, Castelletti CM, Malesci A, Frigo GM (1993) Immunological adverse events of anti-convulsants. Drug Saf 8:235-250
6. Verrotti A, Basciani F, Trotta D, Greco R, Morgese G, Chiarelli F (2001) Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1. Clin Exp Med 1:133-136
7. Verrot D, SanMarco M, Dravet C, Genton P, Disdier P, Bolla G, Harle JR, Reynaud L, Weiller PJ (1997) Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy. Am J Med 103:33-37
8. Peltola JT, Haapala AM, Isojärvi JI, Auvinen A, Palmio J, Latvala K, Kulmala P, Laine S, Vaarala O, Keränen T (2000) Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am J Med 109:712-717
9. Pardo A, Gonzalez-Porque P, Gobernado JM, Jimenez-Escrig A, Lou M (2001) Study of antiphospholipid antibodies in patients treated with antiepileptic drugs. Neurologia 16:7-10
10. 2 glycoprotein I and anti-prothrombin antibodies in young patients with epilepsy. Epilepsia 43:52-59
11. Spreafico R, Binelli S, Bruzzone MG (1994) Primary antiphospholipid syndrome (PAPS) and isolated partial seizures in adolescence: a case report. Ital J Neurol Sci 15:297-301
12. Angelini L, Granata T, Zibordi F (1998) Partial seizures associated with antiphospholipid antibodies in childhood. Neuropediatrics 29:249-253
13. Peltola J, Kulmala P, Isojärvi J, Saiz A, Latvala K, Palmio J, Savola K, Knip M, Keränen T, Graus F (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55:46-50
14. Kwan P, Sills GJ, Kelly K, Butler E, Brodie MJ (2000) Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 42:191-195
15. Commission on Classification and Terminology of the International League against Epilepsy (1989) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 30:389-390
16. Verrotti A, Cieri F, Pelliccia P, Morgese G, Chiarelli F (2000) Lack of association between antiphospholipid antibodies and migraine in children. Int J Clin Lab Res 30:109-111
17. Schranz DB, Lernmark A (1998) Immunology in diabetes: an update. Diabetes Metab Rev 14:3-29
18. Tan EM, Feltkamp TEW, Smolen JS (1997) Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 40:1601-1611
19. Kavanaugh AF, Solomon DH, The American College of Rheumatology ad hoc Committee on Immunologic Testing Guidelines (2002) Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum 47:546-555
20. Asherson RA, Cervera R, Gharavi AE (1993) Antiphospholipid antibodies and the antiphospholipid syndrome. Ann Med Int 144:367-376
21. Bick RL (1993) Fact, fiction, confusion and controversy. Am J Clin Pathol 100:477-480
22. Chancellor A, Cull R, Kilpatrick D, Warlow C (1991) Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features. J Neurol 238:401-407
23. Chengappa KN, Carpenter AB, Keshavan MS (1991) Elevated IgG and IgM anticardiolipin antibodies in a sub-group of medicate and unmedicated schizophrenic patients. Biol Psychiatry 30:731-735
24. Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GRV (1994) Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 37:568-571
25. Greaves M (1999) Antiphospholipid antibodies and thrombosis. Lancet 353:1348-1353
26. Kajiwara K, Nagawawa H, Shimizu-Nishikawa K (1996) Molecular characterization of seizure-related genes isolated by differential screening. Biochem Biophys Res Commun 219:795-799
27. Fitzgerald LR, Vaidya VA, Terwilliger RZ, Duman RS (1996) Electroconvulsive seizure increases the expression of CREM (cyclic AMP response element modulator) and ICER (inducible cyclic AMP early repressor) in rat brain. J Neurochem 66:429-432
28. Toubi E, Kamashta MA, Panarra A, Hughes GRV (1995) Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 99:397-401
29. Asherson RA, Khamashta MA, Gil A (1989) Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid syndrome. Am J Med 86:391-399
30. Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD (1999) Antiphospholipid antibodies permealize and depolarize brain synaptoneurosomes. Lupus 8:127-133
31. Liou HH, Wang CR, Chou HC (1994) Anticardiolipin antisera from lupus patients with seizures reduce GABA receptor-mediated chloride current in snail neurons. Life Sci 54:1119-1125
32. Bordron A, Dueymes M, Levy Y (1998) The binding of some human antiendothelial cells antibodies induces endothelial cell apoptosis. J Clin Invest 101:2029-2035
33. Kent M, Alvarez F, Bogt E (1997) Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. J Rheumatol 24:1725-1733
34. Saiz A, Arpa J, Sagasta A (1997) Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 49:1026-1030
35. Nemni R, Braghi S, Natali-Sora MG (1994) Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol 36:665-667
36. Giometto B, Nicolao P, Macucci M, Tavolato B, Foxon R, Bottazzo GF (1998) Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 352:457